Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
European Journal of Neurology
|
October 20, 2021
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series
Leon D Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 1, 2018
Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach
Andreas Funke, Susanne Spittel, Torsten Grehl, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
Baltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Brain : a Journal of Neurology
|
January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathy
Marcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
Brain : a Journal of Neurology
|
January 18, 2018
Hot-spot KIF5A mutations cause familial ALS
David Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
European Journal of Neurology
|
October 20, 2021
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series
Leon D Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 1, 2018
Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach
Andreas Funke, Susanne Spittel, Torsten Grehl, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
Baltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Brain : a Journal of Neurology
|
January 18, 2021
Bi-allelic truncating mutations in VWA1 cause neuromyopathy
Marcus Deschauer, Holger Hengel, Katrin Rupprich, et al.
Brain : a Journal of Neurology
|
January 18, 2018
Hot-spot KIF5A mutations cause familial ALS
David Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Page
of 3